1. Home
  2. GLBS vs PLUR Comparison

GLBS vs PLUR Comparison

Compare GLBS & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globus Maritime Limited

GLBS

Globus Maritime Limited

HOLD

Current Price

$1.75

Market Cap

35.0M

ML Signal

HOLD

Logo Pluri Inc.

PLUR

Pluri Inc.

HOLD

Current Price

$3.24

Market Cap

28.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLBS
PLUR
Founded
2006
2001
Country
Greece
Israel
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.0M
28.4M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
GLBS
PLUR
Price
$1.75
$3.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$3.00
$12.00
AVG Volume (30 Days)
94.0K
26.6K
Earning Date
11-28-2025
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$39,444,000.00
$1,326,000.00
Revenue This Year
$24.03
$97.38
Revenue Next Year
$13.92
$293.97
P/E Ratio
N/A
N/A
Revenue Growth
18.49
121.74
52 Week Low
$0.99
$2.82
52 Week High
$1.99
$7.13

Technical Indicators

Market Signals
Indicator
GLBS
PLUR
Relative Strength Index (RSI) 59.33 N/A
Support Level $1.62 N/A
Resistance Level $1.82 N/A
Average True Range (ATR) 0.08 0.00
MACD -0.01 0.00
Stochastic Oscillator 55.00 0.00

Price Performance

Historical Comparison
GLBS
PLUR

About GLBS Globus Maritime Limited

Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: